NIH-funded research U01 cooperative agreement

Collaborative work to improve flu and other respiratory illnesses monitoring in South Africa

Official title: IP24-017 - Collaborative research on influenza and other respiratory pathogens in South Africa

Funded at National Health Laboratory Service · NIH-11386077 · Data updated 2026-11-12

A U01 grant funds a project in South Africa to strengthen how we watch flu and other respiratory illnesses and to help tailor vaccines and interventions for people in Africa.

More Influenza research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionNational Health Laboratory Service
NIH-funded
Lab location1 site (Johannesburg, South Africa)
Project startSeptember 1, 2024
Project endAugust 31, 2027
Funding year2026
Award (this year)$100,000
NIH project number5U01IP001269-03
Project IDNIH-11386077 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals in South Africa and nearby regions who experience respiratory symptoms or participate in digital surveillance programs.

Less likely to help

Patients outside surveillance networks or in areas without access to the digital platform may see limited direct benefit.

What this research studies

This project aims to build better data for tracking respiratory illnesses like influenza across South Africa and neighboring countries. It will expand digital participatory surveillance so people can report symptoms online and help detect outbreaks quickly. It also tests how timing and location of viral data affects our understanding of which flu strains are circulating to improve vaccine decisions, while training regional staff in next-generation sequencing.

Why it matters

Potential benefit: If successful, communities could see earlier outbreak alerts, more targeted prevention measures, and better-informed vaccine choices.

How similar studies have gone: Similar digital surveillance and genomic surveillance efforts have shown value in early outbreak detection and vaccine strain selection, but regional expansion remains a key area.

Where this research is happening

  • National Health Laboratory Service
    Johannesburg, South Africa
    Active

Researchers

  • Principal investigator: Cohen, Cheryl — National Health Laboratory Service
  • Study coordinator: Cohen, Cheryl

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.